Over the last 7 days, the United States market has experienced a 3.0% drop, yet it remains up by 7.5% over the past year with earnings anticipated to grow by 14% annually in the coming years. In this dynamic environment, identifying high growth tech stocks involves focusing on companies that exhibit strong innovation and adaptability to capitalize on these projected earnings growth trends. Top 10 High Growth Tech Companies In The United States\n\nName\tRevenue Growth\tEarnings Growth\tGrowth Rating\nSuper Micro Computer\t20.44%\t29.79%\t★★★★★★\nTG Therapeutics\t26.18%\t37.61%\t★★★★★★\nAlkami Technology\t20.46%\t85.16%\t★★★★★★\nTravere Therapeutics\t28.40%\t64.74%\t★★★★★★\nClene\t60.86%\t63.07%\t★★★★★★\nAlnylam Pharmaceuticals\t22.69%\t58.49%\t★★★★★★\nAVITA Medical\t27.91%\t55.77%\t★★★★★★\nTKO Group Holdings\t22.48%\t25.17%\t★★★★★★\nLumentum Holdings\t21.55%\t119.67%\t★★★★★★\nAscendis Pharma\t32.36%\t59.79%\t★★★★★★\n\nSimply Wall St Growth Rating: ★★★★☆☆\nOverview: BigCommerce Holdings, Inc. provides a software-as-a-service ecommerce platform for brands and retailers across various regions globally, with a market cap of $452.74 million. Operations: The company generates revenue primarily from its software-as-a-service ecommerce platform, with $332.93 million attributed to Internet Information Providers. BigCommerce Holdings is positioning itself as a pivotal player in the digital transformation of the electrical distribution industry through its strategic partnership with NAED. This collaboration, aimed at fostering innovation and workforce development, underscores BigCommerce's commitment to enhancing its B2B commerce capabilities for manufacturers and distributors. The company's recent executive hires, including SaaS veteran Andrew Norman to spearhead EMEA operations, further signal its intent to expand and adapt in a competitive market. Despite reporting a narrowed net loss from $64.67 million to $27.03 million year-over-year and an increase in annual sales to $332.93 million, BigCommerce's revenue growth projection of 5.2% trails the U.S market average of 8.3%. However, with anticipated earnings growth of 47.27% per year and strategic initiatives like the transformative partnership with Pipe17 enhancing order management efficiencies, BigCommerce is crafting a robust foundation for future profitability and market relevance. Simply Wall St Growth Rating: ★★★★★☆\nOverview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs globally, with a market cap of $267.67 million. Operations: Vanda Pharmaceuticals generates revenue primarily from its biotechnology segment, amounting to $198.77 million. The company focuses on developing and commercializing therapies for unmet medical needs globally. Vanda Pharmaceuticals is navigating a dynamic phase with its recent submission of a New Drug Application for Bysanti, targeting acute bipolar I disorder and schizophrenia, demonstrating an aggressive push into new therapeutic areas. This move aligns with an impressive projected annual revenue growth of 28.8%, outpacing the broader U.S. market's 8.3% growth rate. Despite current unprofitability, Vanda's strategic R&D investments are set to foster significant earnings growth, estimated at 58.32% annually, positioning it well for future profitability within three years. The company's focus on innovative treatments for complex psychiatric and neurological conditions underscores its commitment to addressing unmet medical needs through targeted research and development efforts.

High Growth Tech Stocks In US With Promising Potential

The article highlights the top 10 high-growth tech companies in the United States, focusing on their revenue growth, earnings growth, and overall market performance. Despite a 3.0% market drop over the past week, the U.S. market remains up by 7.5% over the past year, with expected earnings growth of 14% annually. The article provides a detailed overview of each company's performance, market cap, and strategic initiatives.